Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 556 AL 570

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study

Li LL, Wang RZ, Wang Z, Hu H, Xu W, Zhu L, Sun Y, Chen KL, Chen SF, He XY, Yuan MY, Huang YY, Liu XY, Liu P, Ye QY, Wang J, Ju ZZ, Zhang W, Hu B, Guo Y, Cao XY, Li YX, Zuo CT, Cheng W, Jiang T, Tan L, Chen XC, Zhao QH, Cui M, Peng GP, Xin JW, Yu JT.

Brain. 2026 Jun 3;149(6):1973-1985. doi: 10.1093/brain/awaf427.

The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease

Zammit MD, Bruzzone H, Cody KA, Morse J, Wilson R, Bettcher BT, McLachlan MJ, McVea AK, DiFilippo AH, Carey FJ, Janelidze S, Hansson O, Price JC, Laymon CM, Minhas DS, Luo W, Rosas HD, Lai F, Lee JH, Lao PJ, Ances BM, Krinsky-McHale SJ, Hom CL, Hartley SL, Zaman SH, Johnson SC, Cohen AD, Head E, Mapstone ME, Handen BL, Christian BT, Tudorascu DL, Langhough RE, Betthauser TJ; Alzheimer Biomarker Consortium–Down Syndrome.

Brain. 2026 Jul 7;149(7):2449-2462. doi: 10.1093/brain/awaf428.

Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review

Jiang H, Escamilla S, Beestrum M, Salas-Lucia F.

Eur J Health Econ. 2026 Jul;27(5):1103-1115. doi: 10.1007/s10198-025-01877-1. Epub 2025 Dec 12.

Kidney Function and Blood and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Related Dementias: Systematic Review and Meta-Analysis

Lin Y, Zhao Z, Zhu N, Garcia Ptacek S, Carrero JJ, Bruchfeld A, Eriksdotter M, Mielke MM, Brusselaers N, Xu H.

J Am Soc Nephrol. 2026 Jul 1;37(7):1507-1523. doi: 10.1681/ASN.0000001007. Epub 2026 Jan 26.

Alzheimer's disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies

Chen PH, Hsu JL.

J Formos Med Assoc. 2026 Jun;125 Suppl 1:S13-S16. doi: 10.1016/j.jfma.2026.01.035. Epub 2026 Jan 27.

Prognostic value of plasma NfL and GFAP for conversion to Alzheimer's disease and dementia in MCI: a systematic review and robust Bayesian meta-analysis

Özkurt Ç, Kelicen-Uğur P.

Biomarkers. 2026 Jun;31(4):326-338. doi: 10.1080/1354750X.2026.2633568. Epub 2026 Jun 18.

Rational Use of Blood-Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype

Reuben DB, Chambliss AB, Katz BJ, López AS, Hinman JD.

J Am Geriatr Soc. 2026 Jun;74(6):1543-1547. doi: 10.1111/jgs.70384. Epub 2026 Mar 19.

Comparison of the analytical and clinical performance of three immunoassay platforms for plasma glial fibrillary acidic protein in Alzheimer's disease

Wang Y, Ma X, Zou Y, Wang T, Chu S, Mao C, Yu S, Gao J, Qiu L.

Clin Chem Lab Med. 2026 Apr 2;64(9):2007-2017. doi: 10.1515/cclm-2025-1694. Print 2026 Aug 24.

The role of olfactory and salivary gland pathways in periodontal disease-mediated Alzheimer's disease progression: mechanistic insights and early diagnostic implications

Liang H, Yu W, Han Z, Xu B, Zhuang Z, Liu J.

Acta Clin Belg. 2026 Aug;81(4):330-346. doi: 10.1080/17843286.2026.2652268. Epub 2026 Apr 4.

Dementia risk factor assessment in a local Alzheimer's prevention population: a German cross-sectional, observational study

Sannemann L, Gerards M, Bohr L, Brosseron F, Escher C, Kalthegener F, Müller T, Ramírez A, Zeyen P, Jessen F, Rostamzadeh A.

J Prev Alzheimers Dis. 2026 Jun;13(6):100556. doi: 10.1016/j.tjpad.2026.100556. Epub 2026 Apr 3.

Cerebrospinal fluid biomarkers in Alzheimer's disease: enhancing diagnostic precision and guiding therapeutic strategies

Azadovich AP, Oralov B, Sherzod K, Kudeshova G, Feruza A, Umida B, Kambarova O, Farkhod R, Baxtiyor S, Jurabek Y, Narzikulova K, Nazirova S, Egamberdieva S.

Clin Chim Acta. 2026 Jul 15;589:121010. doi: 10.1016/j.cca.2026.121010. Epub 2026 Apr 16.

Cost analyses of plasma p-tau217 versus p-tau217/Aβ42 ratio using two-step approach in the Japanese health care system

Kurihara M, Ihara R, Sato K, Iwata A.

J Prev Alzheimers Dis. 2026 Jun;13(6):100572. doi: 10.1016/j.tjpad.2026.100572. Epub 2026 Apr 18.

Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial

Dhana K, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.

J Alzheimers Dis. 2026 Jun;111(3):1301-1308. doi: 10.1177/13872877261442856. Epub 2026 Apr 25.

Multi-ancestry studies in multi-omics of Alzheimer's disease: Recent insights and future directions

Shir D, Seifar F, Ertekin-Taner N.

Curr Opin Neurobiol. 2026 Aug;99:103205. doi: 10.1016/j.conb.2026.103205. Epub 2026 Apr 24.

Bridging the gaps in Alzheimer's disease biomarker research: From multi-omics integration to point-of-care diagnostics, a comprehensive review

Khasanov S, Tolibov M, Daminova N.

Clin Chim Acta. 2026 Jul 15;589:121046. doi: 10.1016/j.cca.2026.121046. Epub 2026 Apr 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias